
Recognizing Progressive Pulmonary Fibrosis (PPF)
24-10-2023

A First-In-Class IFN-1 Signaling Inhibitor, Now With 4-Year Data From a Long-Term Safety and Tolerability Study
24-10-2023

Exploring a Treatment that Addresses Multiple Domains with a Well-Documented Safety Profile for Adult Patients with Active PsA
24-10-2023

Considerations and Choices in Treating Adults with Active Psoriatic Arthritis
25-10-2023

Use of an Approved JAK Inhibitor in a Patient Scenario With Moderate to Severe Rheumatoid Arthritis
25-10-2023

Translating a Decade-long Evidence Journey into Meaningful Clinical Action
25-10-2023

Clinical Experiences in DMPM and SLE
26-10-2023